Literature DB >> 19627191

How do natural killer T cells help B cells?

Mark L Lang1.   

Abstract

CD1d-restricted natural killer (NKT) cells are important contributors to antigen-specific antibody responses. There is, therefore, considerable interest in the design and implementation of strategies to appropriately activate NKT cells and boost vaccine-induced protective antibody responses. In order to achieve these goals, investigators are examining the mechanisms by which NKT cells enhance antibody responses. Although information is limited, it is now appreciated that both cognate and noncognate interactions between CD1d-expressing B cells and NKT cells drive enhanced antibody responses. NKT cells may provide B-cell help in the form of direct receptor-mediated interactions as well as by secretion of soluble effectors, including cytokines. In this article, we review the evidence in support of these mechanisms and discuss how they likely take place in the context of interactions of NKT cells with other cell types, such as dendritic cells and helper T cells. We also discuss the evidence that NKT cells affect discrete differentiation events in the multistep process by which a naive B cell experiences antigen and develops into a memory B cell or an antibody-secreting plasma cell. Since most information on NKT cells and humoral immunity has been derived from murine studies, we discuss what is known about human NKT cells and humoral immunity. We offer thoughts on whether the findings in murine systems will translate to humans.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19627191      PMCID: PMC2747240          DOI: 10.1586/erv.09.56

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  123 in total

1.  CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4.

Authors:  S K Mendiratta; W D Martin; S Hong; A Boesteanu; S Joyce; L Van Kaer
Journal:  Immunity       Date:  1997-04       Impact factor: 31.745

Review 2.  Long-lived plasma cells: a mechanism for maintaining persistent antibody production.

Authors:  M K Slifka; R Ahmed
Journal:  Curr Opin Immunol       Date:  1998-06       Impact factor: 7.486

3.  Humoral immunity due to long-lived plasma cells.

Authors:  M K Slifka; R Antia; J K Whitmire; R Ahmed
Journal:  Immunity       Date:  1998-03       Impact factor: 31.745

Review 4.  [Development of KRN7000, derived from agelasphin produced by Okinawan sponge].

Authors:  T Natori; K Akimoto; K Motoki; Y Koezuka; T Higa
Journal:  Nihon Yakurigaku Zasshi       Date:  1997-10

5.  CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides.

Authors:  T Kawano; J Cui; Y Koezuka; I Toura; Y Kaneko; K Motoki; H Ueno; R Nakagawa; H Sato; E Kondo; H Koseki; M Taniguchi
Journal:  Science       Date:  1997-11-28       Impact factor: 47.728

6.  Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors.

Authors:  J Cui; T Shin; T Kawano; H Sato; E Kondo; I Toura; Y Kaneko; H Koseki; M Kanno; M Taniguchi
Journal:  Science       Date:  1997-11-28       Impact factor: 47.728

7.  Crystal structure of mouse CD1: An MHC-like fold with a large hydrophobic binding groove.

Authors:  Z Zeng; A R Castaño; B W Segelke; E A Stura; P A Peterson; I A Wilson
Journal:  Science       Date:  1997-07-18       Impact factor: 47.728

8.  CD1 expression defines subsets of follicular and marginal zone B cells in the spleen: beta 2-microglobulin-dependent and independent forms.

Authors:  M Amano; N Baumgarth; M D Dick; L Brossay; M Kronenberg; L A Herzenberg; S Strober
Journal:  J Immunol       Date:  1998-08-15       Impact factor: 5.422

9.  Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes.

Authors:  N Burdin; L Brossay; Y Koezuka; S T Smiley; M J Grusby; M Gui; M Taniguchi; K Hayakawa; M Kronenberg
Journal:  J Immunol       Date:  1998-10-01       Impact factor: 5.422

10.  Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells.

Authors:  U Klein; K Rajewsky; R Küppers
Journal:  J Exp Med       Date:  1998-11-02       Impact factor: 14.307

View more
  21 in total

1.  Differential contribution of dendritic cell CD1d to NKT cell-enhanced humoral immunity and CD8+ T cell activation.

Authors:  Sunil K Joshi; Gillian A Lang; T Scott Devera; Amy M Johnson; Susan Kovats; Mark L Lang
Journal:  J Leukoc Biol       Date:  2012-02-13       Impact factor: 4.962

2.  Type II NKT cells facilitate Alum-sensing and humoral immunity.

Authors:  Hemangi B Shah; T Scott Devera; Pragya Rampuria; Gillian A Lang; Mark L Lang
Journal:  J Leukoc Biol       Date:  2012-07-13       Impact factor: 4.962

Review 3.  Fine tuning a well-oiled machine: Influence of NK1.1 and NKG2D on NKT cell development and function.

Authors:  Sunil K Joshi; Mark L Lang
Journal:  Int Immunopharmacol       Date:  2013-06-22       Impact factor: 4.932

4.  The early activation of memory B cells from Wiskott-Aldrich syndrome patients is suppressed by CD19 downregulation.

Authors:  Xiaoming Bai; Yongjie Zhang; Lu Huang; Jinzhi Wang; Wenyan Li; Linlin Niu; Hongyan Jiang; Rongxin Dai; Lina Zhou; Zhiyong Zhang; Heather Miller; Wenxia Song; Xiaodong Zhao; Chaohong Liu
Journal:  Blood       Date:  2016-06-21       Impact factor: 22.113

Review 5.  Developing understanding of the roles of CD1d-restricted T cell subsets in cancer: reversing tumor-induced defects.

Authors:  Mark A Exley; Lydia Lynch; Bindu Varghese; Michael Nowak; Nadia Alatrakchi; Steven P Balk
Journal:  Clin Immunol       Date:  2011-05-13       Impact factor: 3.969

6.  SAP expression in invariant NKT cells is required for cognate help to support B-cell responses.

Authors:  Cynthia Detre; Marton Keszei; Natividad Garrido-Mesa; Katalin Kis-Toth; Wilson Castro; Amma F Agyemang; Natacha Veerapen; Gurdyal S Besra; Michael C Carroll; George C Tsokos; Ninghai Wang; Elizabeth A Leadbetter; Cox Terhorst
Journal:  Blood       Date:  2012-05-21       Impact factor: 22.113

7.  BAFF- and APRIL-dependent maintenance of antibody titers after immunization with T-dependent antigen and CD1d-binding ligand.

Authors:  Hemangi B Shah; Sunil K Joshi; Pragya Rampuria; T Scott Devera; Gillian A Lang; William Stohl; Mark L Lang
Journal:  J Immunol       Date:  2013-06-24       Impact factor: 5.422

8.  Differences of the immune cell landscape between normal and tumor tissue in human prostate.

Authors:  E Zhang; F Dai; Y Mao; W He; F Liu; W Ma; Y Qiao
Journal:  Clin Transl Oncol       Date:  2019-05-10       Impact factor: 3.405

9.  Specific humoral immunity versus polyclonal B cell activation in Trypanosoma cruzi infection of susceptible and resistant mice.

Authors:  Marianne A Bryan; Siobhan E Guyach; Karen A Norris
Journal:  PLoS Negl Trop Dis       Date:  2010-07-06

10.  The importance of B cell CD1d expression for humoral immunity.

Authors:  Mark L Lang
Journal:  Expert Rev Vaccines       Date:  2014-06-20       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.